RecruitingPhase 4NCT03082755

Nighttime Agitation and Restless Legs Syndrome in People With Alzheimer's Disease

Studying NON RARE IN EUROPE: Alzheimer disease

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of Texas at Austin
Principal Investigator
Kathy Richards, PhD
The University of Texas at Austin
Intervention
Gabapentin Enacarbil(drug)
Enrollment
156 enrolled
Eligibility
55 years · All sexes
Timeline
20172023

Study locations (1)

Collaborators

National Institute on Aging (NIA)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03082755 on ClinicalTrials.gov

Other trials for NON RARE IN EUROPE: Alzheimer disease

Additional recruiting or active studies for the same condition.

See all trials for NON RARE IN EUROPE: Alzheimer disease

← Back to all trials